The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases.
autoinflammatory diseases
international registry
personalized medicine
precision medicine
rare diseases
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
06
2022
accepted:
08
08
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
epublish
Résumé
The present manuscript aims to describe an international, electronic-based, user-friendly and interoperable patient registry for monogenic autoinflammatory diseases (mAIDs), developed in the contest of the Autoinflammatory Diseases Alliance (AIDA) Network. This is an electronic platform, based on the Research Electronic Data Capture (REDCap) tool, used for real-world data collection of demographics, clinical, laboratory, instrumental and socioeconomic data of mAIDs patients. The instrument has flexibility, may change over time based on new scientific acquisitions, and communicate potentially with other similar registries; security, data quality and data governance are corner stones of the platform. AIDA project will share knowledge and expertise on mAIDs. Since its start, 118 centers from 24 countries and 4 continents have joined the AIDA project. Fifty-nine centers have already obtained the approval from their local Ethics Committees. Currently, the platform counts 337 users (122 Principal Investigators, 210 Site Investigators, 2 Lead Investigators, and 3 data managers). The Registry collects baseline and follow-up data using 3,748 fields organized into 21 instruments, which include demographics, patient history, symptoms, trigger/risk factors, therapies, and healthcare information for mAIDs patients. The AIDA mAIDs Registry, acts both as a research tool for future collaborative real-life studies on mAIDs and as a service to connect all the figures called to participate. On this basis, the registry is expected to play a pivotal role in generating new scientific evidence on this group of rare diseases, substantially improving the management of patients, and optimizing the impact on the healthcare system. NCT05200715 available at https://clinicaltrials.gov.
Identifiants
pubmed: 36160138
doi: 10.3389/fmed.2022.980679
pmc: PMC9500177
doi:
Banques de données
ClinicalTrials.gov
['NCT05200715']
Types de publication
Journal Article
Langues
eng
Pagination
980679Informations de copyright
Copyright © 2022 Gaggiano, Vitale, Tufan, Ragab, Aragona, Wiesik-Szewczyk, Ait-Idir, Conti, Iezzi, Maggio, Cattalini, Torre, Lopalco, Verrecchia, Paulis, Sahin, Insalaco, Sfikakis, Marino, Frassi, Ogunjimi, Opris-Belinski, Parronchi, Emmi, Shahram, Ciccia, Piga, Hernández-Rodríguez, Pereira, Alessio, Naddei, Olivieri, Giudice, Sfriso, Ruscitti, Gobbi, Kucuk, Sota, Hussein, Malizia, Jahnz-Różyk, Sari-Hamidou, Romeo, Ricci, Cardinale, Iannone, Casa, Natale, Laskari, Giani, Franceschini, Sabato, Yildirim, Caggiano, Hegazy, Marzo, Kucharczyk, Khellaf, Tarsia, Almaghlouth, Laymouna, Mastrorilli, Dotta, Benacquista, Grosso, Crisafulli, Parretti, Giordano, Mahmoud, Nuzzolese, Musso, Chighizola, Gentileschi, Morrone, Cola, Spedicato, Giardini, Vasi, Renieri, Fabbiani, Mencarelli, Frediani, Balistreri, Tosi, Fabiani, Lidar, Rigante and Cantarini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Med Genet. 2018 Aug;55(8):530-537
pubmed: 29599418
Rheumatology (Oxford). 2009 Apr;48(4):395-8
pubmed: 19193696
Ann Rheum Dis. 2017 Jun;76(6):942-947
pubmed: 27707729
Arthritis Rheumatol. 2022 Jul;74(7):1102-1121
pubmed: 35621220
Nat Immunol. 2017 Jul 19;18(8):832-842
pubmed: 28722725
Pharmaceut Med. 2020 Jun;34(3):185-190
pubmed: 32215853
Ann Rheum Dis. 2022 May;81(5):601-613
pubmed: 35086813
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Arthritis Rheum. 1997 Oct;40(10):1879-85
pubmed: 9336425
Orphanet J Rare Dis. 2020 Jan 30;15(1):33
pubmed: 32000824
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101529
pubmed: 32546426
Public Health Genomics. 2013;16(6):299-304
pubmed: 24503590
Clin Chem. 2020 Apr 1;66(4):525-536
pubmed: 32176780
Arch Public Health. 2014 Oct 13;72(1):35
pubmed: 25352985
Ophthalmol Ther. 2022 Apr;11(2):899-911
pubmed: 35099782
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Ophthalmol Ther. 2022 Apr;11(2):887-897
pubmed: 35092604
Ann Rheum Dis. 2019 Aug;78(8):1025-1032
pubmed: 31018962
Front Med (Lausanne). 2022 Apr 07;9:878797
pubmed: 35463015
Biomed Res Int. 2013;2013:485103
pubmed: 23971037
Adv Exp Med Biol. 2017;1031:149-164
pubmed: 29214570
Int J Environ Res Public Health. 2018 Aug 03;15(8):
pubmed: 30081484